Foot and mouth disease leader protease (Lb(pro)): Investigation of prime side specificity allows the synthesis of a potent inhibitor
dc.contributor.author | Nogueira Santos, Jorge Alexandre | |
dc.contributor.author | Assis, Diego M. | |
dc.contributor.author | Gouvea, Iuri Estrada | |
dc.contributor.author | Judice, Wagner A. S. | |
dc.contributor.author | Izidoro, Mario Augusto | |
dc.contributor.author | Juliano, Maria Aparecida | |
dc.contributor.author | Skern, Tim | |
dc.contributor.author | Juliano, Luiz [UNIFESP] | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Univ Mogi das Cruzes | |
dc.contributor.institution | Med Univ Vienna | |
dc.date.accessioned | 2016-01-24T14:26:54Z | |
dc.date.available | 2016-01-24T14:26:54Z | |
dc.date.issued | 2012-03-01 | |
dc.description.abstract | Foot and mouth disease virus expresses its genetic information as a single polyprotein that is translated from the single-stranded RNA genome. Proteinases contained within the polyprotein then generate the mature viral proteins. the leader protease (Lb(pro)) performs the initial cleavage by freeing itself from the growing polypeptide chain; subsequently, Lb(pro) cleaves the two homologues of the host cell protein eukaryotic initiation factor 4G (eIF4G). We showed that Lb(pro) possesses specific binding sites at the non prime side from S-1 down to S-7 [Santos et al. (2009) Biochemistry, 48, 7948-7958]. Here, we demonstrate that Lb(pro) has high prime side specificity at least down to the S-5' site. Lb(pro) is thus not only one of the smallest papain-like cysteine peptidases but also one of the most specific. It can still however cleave between both K down arrow G and G down arrow R pairs. We further determined the two-step irreversible inhibition (E + I <-> EI -> E - I) kinetic parameters of two known irreversible epoxide-based inhibitors of cysteine proteinases, E64 and CA074 on Lb(pro) that show for the reversible step (E + I <-> EI) K-i = 3.4 mu M and 11.6 mu M, and for the irreversible step (EI -> E-I) k(4) = 0.16 and 0.06 min(-1), respectively. Knowledge of the Lb(pro) specificity led us to extend E64 by addition of the dipeptide R-P. This compound, termed E64-R-P-NH2, irreversibly inhibited Lb(pro) with a K-i = 30 nM and k(4) = 0.01 min(-1) and can serve as the basis for design of specific inhibitors of FMDV replication. (C) 2011 Elsevier Masson SAS. All rights reserved. | en |
dc.description.affiliation | Universidade Federal de São Paulo, Dept Biophys, Escola Paulista Med, UNIFESP, BR-04044020 São Paulo, Brazil | |
dc.description.affiliation | Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, BR-08780911 Mogi Das Cruzes, Brazil | |
dc.description.affiliation | Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Dept Biophys, Escola Paulista Med, UNIFESP, BR-04044020 São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorship | Instituto Nacional de Ciencia e Tecnologia em Fluidos Complexos (INCT-Fx) in Brazil | |
dc.description.sponsorship | Austrian Science Foundation | |
dc.description.sponsorshipID | Austrian Science Foundation: P20889 | |
dc.format.extent | 711-718 | |
dc.identifier | http://dx.doi.org/10.1016/j.biochi.2011.10.016 | |
dc.identifier.citation | Biochimie. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 94, n. 3, p. 711-718, 2012. | |
dc.identifier.doi | 10.1016/j.biochi.2011.10.016 | |
dc.identifier.issn | 0300-9084 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/34671 | |
dc.identifier.wos | WOS:000301332200015 | |
dc.language.iso | eng | |
dc.publisher | Elsevier B.V. | |
dc.relation.ispartof | Biochimie | |
dc.rights | Acesso restrito | |
dc.rights.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dc.subject | Cysteine protease | en |
dc.subject | Fluorescent peptides | en |
dc.subject | Cathepsin | en |
dc.subject | Picornavirus | en |
dc.subject | Protease inhibitors | en |
dc.title | Foot and mouth disease leader protease (Lb(pro)): Investigation of prime side specificity allows the synthesis of a potent inhibitor | en |
dc.type | Artigo |